The tau S305S mutation causes frontotemporal dementia with parkinsonism.
European Journal of Neurology; 15(2): 156-161.
Inhibition of PHF-like Tau Hyperphosphorylation in SH-SY5Y Cells and Rat Brain Slices by K252a.
Journal of Alzheimer’s Disease; 13(3): 281-294.
MAPT S305I mutation: implications for argyrophilic grain disease.
Acta Neuropathol; 2008 Jul;116(1):103-18. Epub 2007 Dec 8.
Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A B{alpha} Subunit Expression That Correlate with Enhanced Tau Phosphorylation.
The Journal of Neuroscience; 28(45):11477-11487.
Recent progress in oligonucleotide therapeutics: antisense to aptamers.
Expert Opinion on Drug Discovery; 3(9): 997-1009..
Non-toxic concentrations of a-synuclein exacerbate Parkinson’s disease-like cell death by inducing mitochondrial dysfunction.
The Universtiy of Edinburgh; 2008.
Local and Nonlocal Environments around Cis Peptides.
J. Proteome Res; 7(01): 145-153..
Interactive sequences in the molecular chaperone, human αB crystallin modulate the fibrillation of amyloidogenic proteins.
The International Journal of Biochemistry & Cell Biology; 40(5): 954-967..
Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.
Virology; 370(2): 403-414..
A more efficient enzyme-linked immunosorbent assay for measurement of α-synuclein in cerebrospinal fluid.
Journal of Neuroscience Methods; 168(1): 182-185..